COVID-19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: Participants in the intervention group receive 4 times a day (after each meal and before bedtime) and 10 ccs of pomegranate syrup for 21 days each time, in additio
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Positive diagnostic specimen on RT-PCR Men or non-pregnant women over 18 years of age Significant involvement in pulmonary CT scan with pneumonia diagnosis Oxygen saturation (Sao2) of blood less than or equal to 93% in room air Respiratory rate above 24 per minute
Exclusion criteria
Exclusion criteria: Taking medications: (Amitriptyline, Codeine, Desipramine, Flecainide, Fluoxetine, Ondansetron, Tramadol) Pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to clinical improvement. Timepoint: Every day after randomization. Method of measurement: Patients' medical records.;Time to clinical deterioration. Timepoint: Every day after randomization. Method of measurement: Patients' medical records.;Duration of Hospitalization. Timepoint: Every day after randomization. Method of measurement: Patients' medical records. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality. Timepoint: 21th day after randomization. Method of measurement: Patients' medical records.;Clinical improvement in first 7 days of intervention. Timepoint: 7th day after randomization. Method of measurement: Patients' medical records.;Fever. Timepoint: Every day after randomization. Method of measurement: Thermometer.;Respiratory rate. Timepoint: Every day after randomization. Method of measurement: Clinical observation and examination.;Oxygen saturation. Timepoint: Every day after randomization. Method of measurement: Pulse Oximeter.;Systolic blood pressure. Timepoint: Every day after randomization. Method of measurement: Clinical observation and examination.;Duration of respiratory support. Timepoint: Every day after randomization. Method of measurement: Patients' medical records.;Cough. Timepoint: Every day after randomization. Method of measurement: Clinical observation and history taking.;Dyspnea. Timepoint: Every day after randomization. Method of measurement: Clinical observation and history taking.;Fatigue. Timepoint: Every day after randomization. Method of measurement: Clinical observation and history taking.;Myalgia. Timepoint: Every day after randomization. Method of measurement: Clinical observation and history taking.;Headache. Timepoint: Every day after randomization. Method of measurement: Clinical observation and history taking.;Sore throat. Timepoint: Every day after randomization. Method of measurement: Clinical observation and history taking.;Chills. Timepoint: Every day after randomization. Method of measurement: Clinical observation and history taking.;Gastrointestinal adverse events. Timepoint: Every day after randomization. Method of measurement: Clinical observation and history taking.;Thirsty. Timepoint: Every day after randomization. Method of measurement: Clinical observation and history taking.;Duration of respiratory support. Timepoint: Every day after randomization. Method of measurement: Patients' medical records.;Transmiss | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Zahra Lorigooini
Shahre-kord University of Medical Sciences
Outcome results
None listed